[1]
Jankun, J. 2020. COVID-19 pandemic; transmembrane protease serine 2 (TMPRSS2) inhibitors as potential drugs . Translation: The University of Toledo Journal of Medical Sciences. 7, (Apr. 2020), 1–5. DOI:https://doi.org/10.46570/utjms.vol7-2020-361.